Chemomab Therapeutics Share Price (NASDAQ: CMMB)
$3.1
Last updated on
Check the interactive Chemomab Therapeutics Stock chart to analyse performance
Chemomab Therapeutics stock performance
as on August 30, 2025 at 1:29 am IST
- Today's Low:$3.10Today's High:$3.43
0.0%
Downside
Day's Volatility :9.62%
Upside
9.62%
- 52 Weeks Low:$3.1052 Weeks High:$10.20
0.0%
Downside
52 Weeks Volatility :69.61%
Upside
69.61%
Chemomab Therapeutics Stock Returns
Chemomab Therapeutics Ltd Key Stats
Check Chemomab Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Chemomab Therapeutics Stock including INR - Dollar returns
The Chemomab Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Chemomab Therapeutics investment value today
Current value as on today
₹43,650
Returns
Returns from Chemomab Therapeutics Stock
Dollar Returns*
₹5,284 (+5.28%)
Indian investors sentiment towards Chemomab Therapeutics Stock
Global Institutional Holdings in Chemomab Therapeutics Ltd
Name
Holdings %
Analyst Recommendation on Chemomab Therapeutics Stock
Buy
75%Buy
25%Hold
0%Sell
Based on 8 Wall street analysts offering stock ratings for Chemomab Therapeutics(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Chemomab Therapeutics Share Price Target
What analysts predicted
Upside of 856.99%
Target:
$29.67
Current:
$3.10
Chemomab Therapeutics share price target is $29.67, a slight Upside of 856.99% compared to current price of $3.10 as per analysts' prediction.
Chemomab Therapeutics Stock Insights
Price Movement
In the last 7 days, CMMB stock has moved down by -12.9%CMMB vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 131.5%CMMB vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 188.9%
Chemomab Therapeutics Technicals Summary
Sell
Neutral
Buy
Chemomab Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Chemomab Therapeutics Ltd Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| -27.57% | -48.68% | -68.5% | -76.44% | -98.82% |
 | 6.48% | -15.2% | -50.31% | -3.3% | -2.01% |
 | 1.77% | 24.81% | 62.78% | 79.11% | 29.69% |
 | -14.45% | -19.13% | -17.84% | 34.68% | 41.87% |
 | 13.79% | 83.28% | 75.87% | 111.28% | 242.25% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | NA | -0.08 | -1.2 | -0.62 | NA | 1.88 |
| 14.6 | 14.6 | 1.2 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.73 | -0.05 | -0.01 | NA | 34.32 |
| 27.86 | 27.86 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $17.7M | -98.82% | NA | 0.0% |
| Buy | $61.4B | -2.01% | 14.6 | 31.37% |
| NA | $36.5B | 29.69% | NA | -3.89% |
| Buy | $100.5B | 41.87% | 27.86 | 31.86% |
| Buy | $59.5B | 242.25% | NA | -12.96% |
About Chemomab Therapeutics Ltd
Key Management of Chemomab Therapeutics Ltd
Important FAQs about investing in CMMB Stock from India :
What is Chemomab Therapeutics share price today?
Chemomab Therapeutics share price today is $3.10 as on at the close of the market. Chemomab Therapeutics share today touched a day high of $3.43 and a low of $3.10.
What is the 52 week high and 52 week low for Chemomab Therapeutics share?
Chemomab Therapeutics share touched a 52 week high of $10.20 and a 52 week low of $3.10. Chemomab Therapeutics stock price today i.e. is closed at $3.10, lower by 69.61% versus the 52 week high.
How to invest in Chemomab Therapeutics Stock (CMMB) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Chemomab Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Chemomab Therapeutics Shares that will get you 0.4839 shares as per Chemomab Therapeutics share price of $3.10 per share as on August 30, 2025 at 1:29 am IST.
What is the minimum amount required to buy Chemomab Therapeutics Stock (CMMB) from India?
Indian investors can start investing in Chemomab Therapeutics (CMMB) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Chemomab Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025).
Based on Chemomab Therapeutics share’s latest price of $3.10 as on August 30, 2025 at 1:29 am IST, you will get 3.2258 shares of Chemomab Therapeutics. Learn more about
fractional shares .
What are the returns that Chemomab Therapeutics has given to Indian investors in the last 5 years?
Chemomab Therapeutics stock has given -98.82% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
Axogen, Inc.$16.12
-0.62%
Rain Oncology Inc$3.84
-0.26%
Cassava Sciences Inc$2.29
-3.78%
Collegium Pharmaceutical Inc$38.81
+1.2%
Airsculpt Technologies$6.46
-3.0%
Mesoblast$13.81
-13.42%
- Scilex Holding Co
$17.84
-2.14%
Corbus Pharmaceuticals Holdings, Inc.$9.39
-5.15%
Voyager Therapeutics, Inc.$3.37
-0.88%